259 related articles for article (PubMed ID: 15522036)
1. Antibacterial drug discovery: is it all downhill from here?
Projan SJ; Shlaes DM
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
[TBL] [Abstract][Full Text] [Related]
2. Trends in antimicrobial drug development: implications for the future.
Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
[TBL] [Abstract][Full Text] [Related]
4. An overview of the pharmaceutical industry.
Stave GM; Joines R
Occup Med; 1997; 12(1):1-4. PubMed ID: 9153049
[TBL] [Abstract][Full Text] [Related]
5. The abandonment of antibacterials: why and wherefore?
Shlaes DM
Curr Opin Pharmacol; 2003 Oct; 3(5):470-3. PubMed ID: 14559090
[TBL] [Abstract][Full Text] [Related]
6. The epiphany of data warehousing technologies in the pharmaceutical industry.
Barrett JS; Koprowski SP
Int J Clin Pharmacol Ther; 2002 Mar; 40(3):S3-13. PubMed ID: 11911607
[TBL] [Abstract][Full Text] [Related]
7. [Current challenges for the pharmaceutical research industry].
Chalchat B
Ann Pharm Fr; 1993; 51(1):16-25. PubMed ID: 8215118
[TBL] [Abstract][Full Text] [Related]
8. Venturing into drug discovery.
Steinmetz M
Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
[No Abstract] [Full Text] [Related]
9. New safe medicines faster: A proposal for a key action within the European union's 6th framework programme.
Bjerrum OJ
Pharmacol Toxicol; 2000; 86 Suppl 1():23-6. PubMed ID: 10905750
[TBL] [Abstract][Full Text] [Related]
10. In silico drug discovery: tools for bridging the NCE gap.
Larvol BL; Wilkerson LJ
Nat Biotechnol; 1998 May; 16 Suppl():33-4. PubMed ID: 9591262
[No Abstract] [Full Text] [Related]
11. The future challenges facing the development of new antimicrobial drugs.
Coates A; Hu Y; Bax R; Page C
Nat Rev Drug Discov; 2002 Nov; 1(11):895-910. PubMed ID: 12415249
[TBL] [Abstract][Full Text] [Related]
12. Biotechnology's metamorphosis into a drug discovery industry.
Drews J
Nat Biotechnol; 1998 May; 16 Suppl():22-4. PubMed ID: 9591258
[No Abstract] [Full Text] [Related]
13. The power of genomics to transform the biotechnology industry.
Haseltine WA
Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
[No Abstract] [Full Text] [Related]
14. Genetic strategies for antibacterial drug discovery.
Miesel L; Greene J; Black TA
Nat Rev Genet; 2003 Jun; 4(6):442-56. PubMed ID: 12776214
[TBL] [Abstract][Full Text] [Related]
15. Rediscovering plant-based drugs.
Littleton J; Falcone D; Davies HM
Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
[No Abstract] [Full Text] [Related]
16. Why is big Pharma getting out of antibacterial drug discovery?
Projan SJ
Curr Opin Microbiol; 2003 Oct; 6(5):427-30. PubMed ID: 14572532
[TBL] [Abstract][Full Text] [Related]
17. Searching for scalable processes: addressing the challenges in times of increasing complexity.
Federsel HJ
Curr Opin Drug Discov Devel; 2003 Nov; 6(6):838-47. PubMed ID: 14758755
[TBL] [Abstract][Full Text] [Related]
18. Drug companies snub antibiotics as pipeline threatens to run dry.
Clarke T
Nature; 2003 Sep; 425(6955):225. PubMed ID: 13679874
[No Abstract] [Full Text] [Related]
19. Growing pains in AIDS drug development.
Herrera S
Nat Biotechnol; 2004 Oct; 22(10):1194. PubMed ID: 15470440
[No Abstract] [Full Text] [Related]
20. Optimizing the impact of genomics on drug discovery and development.
Crooke ST
Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260
[No Abstract] [Full Text] [Related]
[Next] [New Search]